[go: up one dir, main page]

WO2012012510A3 - Profilage d'expression génique pour l'identification du cancer du poumon - Google Patents

Profilage d'expression génique pour l'identification du cancer du poumon Download PDF

Info

Publication number
WO2012012510A3
WO2012012510A3 PCT/US2011/044648 US2011044648W WO2012012510A3 WO 2012012510 A3 WO2012012510 A3 WO 2012012510A3 US 2011044648 W US2011044648 W US 2011044648W WO 2012012510 A3 WO2012012510 A3 WO 2012012510A3
Authority
WO
WIPO (PCT)
Prior art keywords
identification
gene expression
lung cancer
expression profiling
copd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/044648
Other languages
English (en)
Other versions
WO2012012510A2 (fr
Inventor
Karl Wassmann
Danute M. Bankaitis-Davis
Kathleen Storm
Lisa Siconolfi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DxTerity Diagnostics
Original Assignee
DxTerity Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DxTerity Diagnostics filed Critical DxTerity Diagnostics
Priority to EP11810327.4A priority Critical patent/EP2596131A4/fr
Publication of WO2012012510A2 publication Critical patent/WO2012012510A2/fr
Publication of WO2012012510A3 publication Critical patent/WO2012012510A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des modèles génétiques utiles dans le criblage de patients à risque pour des cancers du poumon, comprenant des fumeurs présentant ou non une maladie pulmonaire obstructive chronique (MPOC).
PCT/US2011/044648 2010-07-21 2011-07-20 Profilage d'expression génique pour l'identification du cancer du poumon Ceased WO2012012510A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11810327.4A EP2596131A4 (fr) 2010-07-21 2011-07-20 Profilage d'expression génique pour l'identification du cancer du poumon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36633110P 2010-07-21 2010-07-21
US61/366,331 2010-07-21

Publications (2)

Publication Number Publication Date
WO2012012510A2 WO2012012510A2 (fr) 2012-01-26
WO2012012510A3 true WO2012012510A3 (fr) 2012-05-24

Family

ID=45497433

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/044648 Ceased WO2012012510A2 (fr) 2010-07-21 2011-07-20 Profilage d'expression génique pour l'identification du cancer du poumon

Country Status (2)

Country Link
EP (1) EP2596131A4 (fr)
WO (1) WO2012012510A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6240804B1 (ja) * 2017-04-13 2017-11-29 大▲連▼大学 改良した情報測定とｇａに基づくフィルター式特徴選択アルゴリズム
CN110699457B (zh) * 2019-10-30 2022-11-25 深圳瑞科生物科技有限公司 检测肺癌的引物组和试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080597A1 (fr) * 2005-01-31 2006-08-03 Digital Genomics Inc. Marqueurs destines au diagnostic de cancer du poumon
AU2007322206A1 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GONZALEZ-ARRIAGA, P. ET AL.: "Polymorphism +17C/G in matrix metalloprotease MP8 decreases lung cancer risk.", BMC CANCER, vol. 8, no. 378, 19 December 2008 (2008-12-19) *
OCAK, S. ET AL.: "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.", EUR. RESPIR. J., vol. 34, no. 2, August 2009 (2009-08-01), pages 489 - 506, XP055072660 *
OHRI, C. M. ET AL.: "Chemokine receptor expression in tumor islets and stroma in non-small cell lung cancer.", BMC CANCER, vol. 10, no. 172, 29 April 2010 (2010-04-29), XP021075011 *
YIN, Z. ET AL.: "ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females.", J. EXP. CLIN. CANCER RES., vol. 28, no. 153, 14 December 2009 (2009-12-14), XP021070230 *

Also Published As

Publication number Publication date
WO2012012510A2 (fr) 2012-01-26
EP2596131A4 (fr) 2013-12-18
EP2596131A2 (fr) 2013-05-29

Similar Documents

Publication Publication Date Title
IL223295A0 (en) Lung cancer biomarkers and uses thereof
IL257330B (en) Compositions, methods and kits for diagnosis of lung cancer
IL252163A0 (en) Lung cancer biomarkers and uses thereof
EP3607089A4 (fr) Profilage de protéine à base de plasma pour le pronostic précoce du cancer du poumon
LT2845593T (lt) Piridino ir pirazino darinys, skirtas lėtinės obstrukcinės plaučių ligos gydymui
PL2134203T3 (pl) Sposoby wytwarzania arkuszy tytoniu odtworzonego
EP2340506A4 (fr) Biomarqueurs de cancer du poumon et utilisations associées
EP2411003A4 (fr) Utilisation de dérivés de l'artémisinine dans le traitement de l'asthme et de la broncho-pneumopathie obstructive chronique (bpco)
EP2401406A4 (fr) Procédés de détection du cancer du poumon
WO2012125712A3 (fr) Système de classification des tumeurs du poumon pour fumeurs et anciens fumeurs.
EP2190351A4 (fr) Système et procédés de mesure de volumes pulmonaires
PL2781913T3 (pl) Sposób wspomagający diagnostykę i terapię astmy i raka płuca
WO2013049152A3 (fr) Procédés pour évaluer le statut du cancer du poumon
EP2694972B8 (fr) Procédés pour prédire et améliorer la survie de patients atteints de cancer gastrique
HUE045731T2 (hu) Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához
EP3152560A4 (fr) Détection de mutation génique non-effractive chez des patients atteints du cancer du poumon
PL3152330T3 (pl) SPOSOBY DIAGNOZOWANIA PRZEWLEKŁEJ OBTURACYJNEJ CHOROBY PŁUC (POChP) Z ZASTOSOWANIEM NOWYCH BIOMARKERÓW MOLEKULARNYCH
GB201608839D0 (en) Biomarkers useful for detectionof types, grades and stages of human breast cancer
EP2921858A4 (fr) Procédé d'obtention de données utiles pour le diagnostic, le pronostic et le classement des patients souffrant d'une broncho-pneumopathie chronique obstructive (bcpo) et/ou d'un cancer du poumon
PL3257953T3 (pl) Sposoby identyfikacji, oceny, zapobiegania i terapii chorób płuc, ich zestawy, w tym do identyfikacji, oceny, zapobiegania i terapii chorób powiązanych z płcią
WO2012012510A3 (fr) Profilage d'expression génique pour l'identification du cancer du poumon
SG11202113075WA (en) Methods for determining the likelihood of lung cancer
EP3909445A4 (fr) Procédé d'évaluation in vitro pour le risque de maladie pulmonaire obstructive chronique associée à un tabagisme ou à une inhalation
WO2012019192A3 (fr) Molécules à perméabilité cellulaire comme antagonistes de récepteurs de facteurs de croissance
EP2647995B8 (fr) Procédés et utilisations pour évaluer la gravité d'une maladie pulmonaire obstructive chronique (COPD)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11810327

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011810327

Country of ref document: EP